Mobile

A study evaluating the Safety and Efficacy of Entospletinib (GS-9973) in combination with standard of care in adult subjects with Relapsed or Refractory Acute Lymphoid Leukemia (ALL)

Update Il y a 4 ans
Reference: EUCTR2015-002768-18

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To evaluate safety of entospletinib (GS-9973) in combination with vincristine (VCR) and dexamethasone in adult subjects with previously treated relapsed or refractory B-cell lineage ALL

Inclusion criteria

  • Relapsed or Refractory Acute Lymphoid Leukemia (ALL)

Links